SIGA Technologies Inc. (SIGA) NASDAQ
$8.48 (0.02) (-0.24%)
Market Cap: $604.28M
As of 03/28/24 11:21 AM EDT. Market open.
SIGA Technologies Inc. (SIGA)
NASDAQ
$8.48
(0.02) (-0.24%)
Market Cap: $604.28M
As of 03/28/24 11:21 AM EDT. Market open.
at siga, we specialize in developing therapeutic solutions for some of the most lethal pathogens – smallpox, ebola, dengue, lassa fever and other dangerous viruses. our objective is to discover, develop, and commercialize drugs to prevent and treat these high-priority ... read more
at siga, we specialize in developing therapeutic solutions for some of the most lethal pathogens – smallpox, ebola, dengue, lassa fever and other dangerous viruses. our objective is to discover, develop, and commercialize drugs to prevent and treat these high-priority threats. read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Miller Larry R. | General Counsel | Mar 25, 2024 | Option Exercise | $8.35 | 19,040 | 158,984 | 30,900 | Mar 27, 2024, 04:16 PM |
Nabel Gary J. | Director | Jun 13, 2023 | Option Exercise | $6.07 | 4,386 | 26,623 | 26,216 | Jun 15, 2023, 05:15 PM |
DURNAN JAYMIE A | Director | Jun 13, 2023 | Option Exercise | $6.07 | 4,386 | 26,623 | 41,216 | Jun 15, 2023, 05:14 PM |
Nemirovsky Julian | Director | Jun 13, 2023 | Option Exercise | $6.07 | 4,386 | 26,623 | 26,216 | Jun 15, 2023, 05:14 PM |
Phillips Holly L. | Director | Jun 13, 2023 | Option Exercise | $6.07 | 4,386 | 26,623 | 26,216 | Jun 15, 2023, 05:13 PM |
Marshall Joseph W III | Director | Jun 13, 2023 | Option Exercise | $6.07 | 4,386 | 26,623 | 198,985 | Jun 15, 2023, 05:12 PM |
Plansky Michael C. | Director | Jun 14, 2022 | Option Exercise | $10.26 | 6,849 | 70,271 | 75,982 | Jun 16, 2022, 05:49 PM |
Phillips Holly L. | Director | Jun 14, 2022 | Option Exercise | $10.26 | 6,849 | 70,271 | 15,982 | Jun 16, 2022, 05:49 PM |
Nemirovsky Julian | Director | Jun 14, 2022 | Option Exercise | $10.26 | 6,849 | 70,271 | 15,982 | Jun 16, 2022, 05:48 PM |
Nabel Gary J. | Director | Jun 14, 2022 | Option Exercise | $10.26 | 6,849 | 70,271 | 15,982 | Jun 16, 2022, 05:47 PM |
Marshall Joseph W III | Director | Jun 14, 2022 | Option Exercise | $10.26 | 6,849 | 70,271 | 188,751 | Jun 16, 2022, 05:45 PM |
Kane Julie | Director | Jun 14, 2022 | Option Exercise | $10.26 | 6,849 | 70,271 | 48,482 | Jun 16, 2022, 05:39 PM |
DURNAN JAYMIE A | Director | Jun 14, 2022 | Option Exercise | $10.26 | 6,849 | 70,271 | 30,982 | Jun 16, 2022, 05:38 PM |
Antal James | Director | Jun 14, 2022 | Option Exercise | $10.26 | 6,849 | 70,271 | 116,857 | Jun 16, 2022, 05:35 PM |
Antal James | Director | Dec 09, 2021 | Sale | $7.82 | 30,000 | 234,600 | 100,875 | Dec 10, 2021, 06:00 PM |
Luckshire Daniel J | Executive VP & CFO | Jul 31, 2021 | Option Exercise | $6.37 | 13,902 | 88,556 | 251,370 | Aug 03, 2021, 04:06 PM |
Abrams Robin Elizabeth | General Counsel and CAO | Jul 31, 2021 | Option Exercise | $6.37 | 11,301 | 71,987 | 49,787 | Aug 03, 2021, 04:05 PM |
Antal James | Director | Aug 27, 2020 | Sale | $7.10 | 30,000 | 213,000 | 115,875 | Aug 28, 2020, 04:22 PM |
Luckshire Daniel J | Executive VP & CFO | Jul 31, 2020 | Option Exercise | $6.42 | 13,005 | 83,492 | 238,605 | Aug 04, 2020, 07:06 PM |
Abrams Robin Elizabeth | General Counsel and CAO | Jul 31, 2020 | Option Exercise | $6.42 | 14,138 | 90,766 | 34,421 | Aug 04, 2020, 06:56 PM |
SAVAS PAUL G | Director | Dec 09, 2019 | Buy | $4.37 | 20,000 | 87,400 | 292,847 | Dec 10, 2019, 04:40 PM |
Kane Julie | Director | Dec 09, 2019 | Buy | $4.39 | 2,500 | 10,975 | 2,500 | Dec 10, 2019, 04:39 PM |
Gomez Phillip Louis III | Chief Executive Officer | Dec 09, 2019 | Buy | $4.42 | 10,000 | 44,200 | 475,782 | Dec 10, 2019, 04:37 PM |
Luckshire Daniel J | Executive VP & CFO | Dec 09, 2019 | Buy | $4.39 | 5,000 | 21,950 | 224,943 | Dec 10, 2019, 04:37 PM |
Gomez Phillip Louis III | Chief Executive Officer | Nov 22, 2019 | Option Exercise | $4.92 | 144,028 | 708,618 | 465,782 | Nov 26, 2019, 07:12 PM |
ROSE ERIC A MD | Director | Nov 22, 2019 | Option Exercise | $4.92 | 54,501 | 268,145 | 1,038,593 | Nov 26, 2019, 07:08 PM |
SAVAS PAUL G | Director | Aug 23, 2019 | Buy | $4.95 | 10,000 | 49,500 | 272,847 | Aug 26, 2019, 08:29 AM |
SAVAS PAUL G | Director | Aug 09, 2019 | Buy | $5.08 | 10,000 | 50,800 | 262,847 | Aug 12, 2019, 05:22 PM |
Luckshire Daniel J | Executive VP & CFO | Jul 31, 2019 | Option Exercise | $5.60 | 12,788 | 71,613 | 219,943 | Aug 02, 2019, 05:27 PM |
Abrams Robin Elizabeth | General Counsel and CAO | Jul 31, 2019 | Option Exercise | $5.60 | 12,788 | 71,613 | 21,892 | Aug 02, 2019, 05:26 PM |
BAYER MICHAEL J | Director | Jun 04, 2019 | Buy | $5.74 | 12,500 | 71,750 | 132,244 | Jul 02, 2019, 05:06 PM |
BAYER MICHAEL J | Director | Oct 16, 2014 | Sale | $1.49 | 13,960 | 20,800 | 119,744 | Jul 02, 2019, 05:06 PM |
BAYER MICHAEL J | Director | Sep 17, 2013 | Buy | $3.59 | 8,284 | 29,740 | 13,960 | Jul 02, 2019, 04:59 PM |
Antal James | Director | Jun 05, 2019 | Sale | $5.70 | 30,000 | 171,000 | 130,875 | Jun 07, 2019, 06:47 PM |
Hruby Dennis E | VP & Chief Scientific Officer | Jun 05, 2019 | Sale | $5.68 | 17,000 | 96,560 | 180,465 | Jun 07, 2019, 06:42 PM |
Hruby Dennis E | VP & Chief Scientific Officer | Jun 07, 2019 | Sale | $5.58 | 16,000 | 89,280 | 147,465 | Jun 07, 2019, 06:42 PM |
Hruby Dennis E | VP & Chief Scientific Officer | Jun 06, 2019 | Sale | $5.57 | 17,000 | 94,690 | 163,645 | Jun 07, 2019, 06:42 PM |
Marshall Joseph W III | Director | Jan 09, 2019 | Option Exercise | $7.78 | 15,231 | 118,497 | 127,769 | Mar 15, 2019, 04:34 PM |
Marshall Joseph W III | Director | Jan 09, 2019 | Option Exercise | $4.74 | 25,000 | 118,500 | 143,000 | Mar 15, 2019, 04:34 PM |
Luckshire Daniel J | Executive VP & CFO | Dec 12, 2018 | Option Exercise | $6.38 | 28,614 | 182,557 | 206,065 | Dec 14, 2018, 05:04 PM |
Luckshire Daniel J | Executive VP & CFO | Dec 12, 2018 | Option Exercise | $3.53 | 58,965 | 208,146 | 234,679 | Dec 14, 2018, 05:04 PM |
ROSE ERIC A MD | Director | Nov 22, 2018 | Option Exercise | $5.55 | 105,896 | 587,723 | 993,094 | Nov 26, 2018, 06:51 PM |
Gomez Phillip Louis III | Chief Executive Officer | Nov 22, 2018 | Option Exercise | $5.55 | 287,543 | 1,595,864 | 315,693 | Nov 26, 2018, 06:48 PM |
SAVAS PAUL G | Director | Nov 16, 2018 | Buy | $5.58 | 5,000 | 27,900 | 237,847 | Nov 19, 2018, 06:01 AM |
Hruby Dennis E | VP & Chief Scientific Officer | Nov 13, 2018 | Sale | $5.29 | 31,099 | 164,514 | 197,465 | Nov 13, 2018, 07:41 PM |
Hruby Dennis E | VP & Chief Scientific Officer | Nov 12, 2018 | Sale | $4.96 | 18,901 | 93,749 | 228,564 | Nov 13, 2018, 07:41 PM |
Gomez Phillip Louis III | Chief Executive Officer | Nov 12, 2018 | Buy | $5.20 | 15,000 | 78,000 | 15,000 | Nov 13, 2018, 05:03 PM |
SAVAS PAUL G | Director | Nov 12, 2018 | Buy | $5.01 | 10,000 | 50,100 | 232,847 | Nov 13, 2018, 06:29 AM |
BAYER MICHAEL J | Director | Oct 16, 2018 | Option Exercise | $5.32 | 14,756 | 78,502 | 119,744 | Oct 18, 2018, 06:20 PM |
BAYER MICHAEL J | Director | Oct 16, 2018 | Option Exercise | $3.14 | 25,000 | 78,500 | 134,500 | Oct 18, 2018, 06:20 PM |
Hruby Dennis E | VP & Chief Scientific Officer | Sep 11, 2018 | Option Exercise | $7.16 | 53,849 | 385,559 | 247,465 | Sep 13, 2018, 07:32 PM |
Hruby Dennis E | VP & Chief Scientific Officer | Sep 11, 2018 | Option Exercise | $4.39 | 68,174 | 299,154 | 267,461 | Sep 13, 2018, 07:32 PM |
ROSE ERIC A MD | Executive Chairman | Aug 20, 2018 | Option Exercise | $7.98 | 234,277 | 1,869,530 | 898,990 | Aug 22, 2018, 06:10 PM |
ROSE ERIC A MD | Executive Chairman | Aug 20, 2018 | Option Exercise | $2.49 | 400,000 | 996,000 | 1,133,267 | Aug 22, 2018, 06:10 PM |
Abrams Robin Elizabeth | General Counsel and CAO | Aug 20, 2018 | Option Exercise | $7.98 | 6,986 | 55,748 | 8,014 | Aug 22, 2018, 06:05 PM |
Antal James | Director | Apr 18, 2018 | Option Exercise | $6.29 | 5,612 | 35,299 | 130,875 | Apr 19, 2018, 05:13 PM |
Antal James | Director | Apr 18, 2018 | Option Exercise | $3.53 | 10,000 | 35,300 | 136,487 | Apr 19, 2018, 05:13 PM |
CONSTANCE THOMAS E | Director | Apr 17, 2018 | Option Exercise | $6.20 | 5,694 | 35,303 | 267,806 | Apr 18, 2018, 04:28 PM |
CONSTANCE THOMAS E | Director | Apr 17, 2018 | Option Exercise | $3.53 | 10,000 | 35,300 | 273,500 | Apr 18, 2018, 04:28 PM |
SAVAS PAUL G | Director | Apr 16, 2018 | Option Exercise | $6.24 | 5,657 | 35,300 | 207,847 | Apr 18, 2018, 04:09 PM |
SAVAS PAUL G | Director | Apr 16, 2018 | Option Exercise | $3.53 | 10,000 | 35,300 | 213,504 | Apr 18, 2018, 04:09 PM |
ROSE ERIC A MD | Executive Chairman | Nov 13, 2017 | Option Exercise | $4.47 | 49,446 | 221,024 | 733,267 | Nov 17, 2017, 04:28 PM |
ROSE ERIC A MD | Executive Chairman | Nov 13, 2017 | Option Exercise | $3.53 | 97,785 | 345,181 | 782,713 | Nov 17, 2017, 04:28 PM |
Hruby Dennis E | VP & Chief Scientific Officer | Nov 10, 2017 | Option Exercise | $4.60 | 29,439 | 135,419 | 208,140 | Nov 14, 2017, 05:11 PM |
Hruby Dennis E | VP & Chief Scientific Officer | Nov 10, 2017 | Option Exercise | $3.53 | 71,168 | 251,223 | 237,579 | Nov 14, 2017, 05:11 PM |
ROSE ERIC A MD | Executive Chairman | Jan 03, 2017 | Option Exercise | $2.93 | 29,502 | 86,441 | 684,928 | Jan 05, 2017, 08:19 PM |
Hruby Dennis E | VP & Chief Scientific Officer | Jan 03, 2017 | Option Exercise | $2.93 | 10,413 | 30,510 | 166,411 | Jan 05, 2017, 08:12 PM |
Luckshire Daniel J | Executive VP & CFO | Jan 03, 2017 | Option Exercise | $2.93 | 14,029 | 41,105 | 175,714 | Jan 05, 2017, 08:05 PM |
Luckshire Daniel J | Executive VP & CFO | Dec 08, 2016 | Option Exercise | $3.13 | 24,611 | 77,032 | 156,409 | Dec 12, 2016, 05:40 PM |
Hruby Dennis E | VP & Chief Scientific Officer | Dec 08, 2016 | Option Exercise | $3.13 | 20,300 | 63,539 | 151,824 | Dec 12, 2016, 05:35 PM |
ROSE ERIC A MD | Executive Chairman | Dec 08, 2016 | Option Exercise | $3.13 | 68,469 | 214,308 | 647,763 | Dec 12, 2016, 05:33 PM |
STERN ANDREW L | Director | Nov 16, 2016 | Option Exercise | $1072.50 | 715 | 766,838 | 62,865 | Nov 18, 2016, 04:38 PM |
SLOVIN BRUCE | Director | Nov 16, 2016 | Option Exercise | $81250.00 | 54,167 | 4,401,068,750 | 179,167 | Nov 18, 2016, 04:36 PM |
SAVAS PAUL G | Director | Nov 16, 2016 | Option Exercise | $99996.50 | 66,664 | 6,666,166,676 | 188,504 | Nov 18, 2016, 04:34 PM |
Marshall Joseph W III | Director | Nov 16, 2016 | Option Exercise | $19500.00 | 13,000 | 253,500,000 | 88,000 | Nov 18, 2016, 04:33 PM |
Luckshire Daniel J | Executive VP & CFO | Nov 16, 2016 | Option Exercise | $15000.00 | 10,000 | 150,000,000 | 114,352 | Nov 18, 2016, 04:31 PM |
KINDLER JEFFREY B | Director | Nov 16, 2016 | Option Exercise | $33508.50 | 22,339 | 748,546,382 | 67,339 | Nov 18, 2016, 04:28 PM |
MacAndrews & Forbes Inc. | Director | Nov 16, 2016 | Option Exercise | $2.49 | 565,010 | 1,406,875 | 24,156,358 | Nov 18, 2016, 04:27 PM |
MacAndrews & Forbes Inc. | Director | Nov 16, 2016 | Option Exercise | $1.50 | 10,060,643 | 15,090,965 | 23,591,348 | Nov 18, 2016, 04:27 PM |
CONSTANCE THOMAS E | Director | Nov 16, 2016 | Option Exercise | $50250.00 | 33,500 | 1,683,375,000 | 248,500 | Nov 18, 2016, 04:26 PM |
BAYER MICHAEL J | Director | Nov 16, 2016 | Option Exercise | $29250.00 | 19,500 | 570,375,000 | 79,500 | Nov 18, 2016, 04:24 PM |
Antal James | Director | Nov 16, 2016 | Option Exercise | $45500.00 | 30,333 | 1,380,151,500 | 111,487 | Nov 18, 2016, 04:21 PM |
ROSE ERIC A MD | Chief Executive Officer | Sep 24, 2015 | Sale | $1.21 | 20,000 | 24,200 | 582,897 | Sep 24, 2015, 04:38 PM |
ROSE ERIC A MD | Chief Executive Officer | Sep 01, 2015 | Sale | $1.32 | 20,000 | 26,400 | 502,897 | Sep 03, 2015, 07:23 PM |
ROSE ERIC A MD | Chief Executive Officer | Jun 22, 2015 | Sale | $1.43 | 25,000 | 35,786 | 493,097 | Jun 24, 2015, 04:33 PM |
Luckshire Daniel J | Executive VP & CFO | Jun 16, 2015 | Sale | $1.54 | 7,500 | 11,550 | 45,602 | Jun 17, 2015, 04:05 PM |
Hruby Dennis E | VP & Chief Scientific Officer | Jun 03, 2015 | Sale | $1.78 | 3,000 | 5,340 | 84,124 | Jun 05, 2015, 05:15 PM |
Hruby Dennis E | VP & Chief Scientific Officer | Jun 05, 2015 | Sale | $1.61 | 32,000 | 51,375 | 74,124 | Jun 05, 2015, 05:15 PM |
Hruby Dennis E | VP & Chief Scientific Officer | Jun 04, 2015 | Sale | $1.61 | 5,000 | 8,050 | 79,124 | Jun 05, 2015, 05:15 PM |
ROSE ERIC A MD | Chief Executive Officer | Jun 03, 2015 | Sale | $1.69 | 12,500 | 21,125 | 460,297 | Jun 04, 2015, 06:47 PM |
ROSE ERIC A MD | Chief Executive Officer | Jun 02, 2015 | Sale | $1.80 | 100 | 180 | 472,797 | Jun 04, 2015, 06:47 PM |
ROSE ERIC A MD | Chief Executive Officer | Jun 04, 2015 | Sale | $1.64 | 12,400 | 20,336 | 447,897 | Jun 04, 2015, 06:47 PM |
Antal James | Director | May 28, 2015 | Option Exercise | $1.22 | 10,000 | 12,200 | 66,154 | Jun 01, 2015, 04:13 PM |
MacAndrews & Forbes Holdings Inc. | Director | Nov 07, 2014 | Buy | $1.52 | 129,727 | 196,913 | 13,509,722 | Nov 10, 2014, 08:05 PM |
MacAndrews & Forbes Holdings Inc. | Director | Nov 06, 2014 | Buy | $1.46 | 70,000 | 102,207 | 13,379,995 | Nov 10, 2014, 08:05 PM |
SLOVIN BRUCE | Director | Sep 26, 2014 | Sale | $1.35 | 25,000 | 33,750 | 95,000 | Sep 29, 2014, 04:43 PM |
MacAndrews & Forbes Holdings Inc. | Director | Sep 24, 2014 | Buy | $1.36 | 52,999 | 71,914 | 13,309,995 | Sep 25, 2014, 07:42 PM |
MacAndrews & Forbes Holdings Inc. | Director | Sep 23, 2014 | Buy | $1.33 | 151,158 | 200,829 | 13,256,996 | Sep 25, 2014, 07:42 PM |
WEINER MICHAEL MD | Director | Mar 13, 2014 | Sale | $3.19 | 15,000 | 47,850 | 0 | Mar 17, 2014, 04:30 PM |
Luckshire Daniel J | Executive VP & CFO | Feb 28, 2014 | Option Exercise | $3.21 | 4,279 | 13,736 | 33,519 | Mar 04, 2014, 05:15 PM |
Hruby Dennis E | VP & Chief Scientific Officer | Feb 28, 2014 | Option Exercise | $3.21 | 9,009 | 28,919 | 87,124 | Mar 04, 2014, 05:09 PM |
ROSE ERIC A MD | Chief Executive Officer | Feb 28, 2014 | Option Exercise | $3.21 | 27,489 | 88,240 | 472,897 | Mar 04, 2014, 05:04 PM |
Luckshire Daniel J | Executive VP & CFO | Jan 03, 2014 | Option Exercise | $3.35 | 14,037 | 47,024 | 26,132 | Jan 07, 2014, 07:12 PM |
Hruby Dennis E | VP & Chief Scientific Officer | Jan 03, 2014 | Option Exercise | $3.35 | 10,412 | 34,880 | 71,133 | Jan 07, 2014, 07:09 PM |
ROSE ERIC A MD | Chief Executive Officer | Jan 03, 2014 | Option Exercise | $3.35 | 29,033 | 97,261 | 433,720 | Jan 07, 2014, 07:06 PM |
Haynes William J II | Executive VP & General Counsel | Jan 03, 2014 | Option Exercise | $3.35 | 11,063 | 37,061 | 13,937 | Jan 07, 2014, 07:04 PM |
Hruby Dennis E | VP & Chief Scientific Officer | Dec 17, 2013 | Option Exercise | $3.07 | 68,403 | 209,997 | 97,344 | Dec 19, 2013, 05:26 PM |
Hruby Dennis E | VP & Chief Scientific Officer | Dec 17, 2013 | Option Exercise | $1.40 | 150,000 | 210,000 | 165,747 | Dec 19, 2013, 05:26 PM |
BAYER MICHAEL J | Director | Sep 17, 2013 | Buy | $3.59 | 9,324 | 33,473 | 15,000 | Sep 18, 2013, 05:19 PM |
BAYER MICHAEL J | Director | Sep 16, 2013 | Buy | $3.57 | 5,676 | 20,263 | 5,676 | Sep 18, 2013, 05:19 PM |
BAYER MICHAEL J | Director | Sep 13, 2013 | Sale | $3.53 | 3,378 | 11,924 | 0 | Sep 16, 2013, 06:01 PM |
BAYER MICHAEL J | Director | Sep 12, 2013 | Sale | $3.55 | 11,622 | 41,258 | 3,378 | Sep 16, 2013, 06:01 PM |
SLOVIN BRUCE | Director | May 30, 2013 | Sale | $3.83 | 15,000 | 57,510 | 105,000 | Jun 03, 2013, 04:15 PM |
Marshall Joseph W III | Director | May 24, 2013 | Buy | $3.59 | 7,000 | 25,130 | 30,000 | May 28, 2013, 04:15 PM |
ROSE ERIC A MD | Chief Executive Officer | Feb 28, 2013 | Option Exercise | $4.28 | 27,314 | 116,904 | 395,987 | Mar 04, 2013, 07:06 PM |
Luckshire Daniel J | Executive VP & CFO | Feb 28, 2013 | Option Exercise | $4.28 | 4,830 | 20,672 | 6,836 | Mar 04, 2013, 07:05 PM |
Hruby Dennis E | VP & Chief Scientific Officer | Feb 28, 2013 | Option Exercise | $4.28 | 9,253 | 39,603 | 15,747 | Mar 04, 2013, 07:03 PM |
Bevins William C | Director | Dec 30, 2011 | Buy | $2.44 | 50,000 | 122,055 | 50,000 | Jan 04, 2012, 04:11 PM |
ROSE ERIC A MD | Chief Executive Officer | Nov 30, 2011 | Option Exercise | $2.10 | 123,666 | 259,699 | 356,635 | Dec 02, 2011, 04:20 PM |
Marshall Joseph W III | Director | Sep 29, 2011 | Buy | $3.02 | 5,000 | 15,100 | 8,000 | Sep 29, 2011, 04:26 PM |
SAVAS PAUL G | Director | Sep 27, 2011 | Buy | $2.82 | 15,000 | 42,300 | 61,840 | Sep 28, 2011, 04:06 PM |
SLOVIN BRUCE | Director | Sep 27, 2011 | Buy | $2.80 | 50,000 | 140,000 | 105,000 | Sep 27, 2011, 06:24 PM |
STERN ANDREW L | Director | Aug 23, 2011 | Buy | $4.99 | 1,500 | 7,490 | 2,150 | Aug 24, 2011, 05:05 PM |
Marshall Joseph W III | Director | Aug 09, 2011 | Buy | $5.45 | 3,000 | 16,350 | 3,000 | Aug 11, 2011, 04:10 PM |
SAVAS PAUL G | Director | Aug 04, 2011 | Buy | $6.29 | 10,000 | 62,900 | 46,840 | Aug 08, 2011, 07:04 AM |
TOWNSEND FRANCES F | Director | Aug 04, 2011 | Buy | $6.08 | 2,000 | 12,166 | 2,000 | Aug 04, 2011, 04:10 PM |
SLOVIN BRUCE | Director | Jun 15, 2011 | Buy | $11.03 | 15,000 | 165,500 | 55,000 | Jun 15, 2011, 05:16 PM |
WEINER MICHAEL MD | Director | May 27, 2011 | Sale | $14.15 | 10,000 | 141,500 | 0 | May 31, 2011, 04:15 PM |
CONSTANCE THOMAS E | Director | May 27, 2011 | Sale | $14.15 | 30,000 | 424,500 | 155,000 | May 31, 2011, 04:04 PM |
ROSE ERIC A MD | Chief Executive Officer | May 25, 2011 | Option Exercise | $13.36 | 81,879 | 1,093,903 | 480,301 | May 26, 2011, 04:33 PM |
WEINER MICHAEL MD | Director | May 19, 2011 | Option Exercise | $3.73 | 10,000 | 37,300 | 19,000 | May 23, 2011, 09:07 PM |
WEINER MICHAEL MD | Director | May 19, 2011 | Sale | $14.01 | 9,000 | 126,090 | 10,000 | May 23, 2011, 09:07 PM |
Hruby Dennis E | Chief Scientific Officer | May 19, 2011 | Option Exercise | $2.50 | 300,000 | 750,000 | 425,000 | May 23, 2011, 04:43 PM |
Hruby Dennis E | Chief Scientific Officer | May 20, 2011 | Sale | $13.51 | 188,000 | 2,539,880 | 195,700 | May 23, 2011, 04:43 PM |
Hruby Dennis E | Chief Scientific Officer | May 19, 2011 | Sale | $13.64 | 41,300 | 563,332 | 383,700 | May 23, 2011, 04:43 PM |
Hruby Dennis E | Chief Scientific Officer | May 23, 2011 | Sale | $13.09 | 70,700 | 925,463 | 125,000 | May 23, 2011, 04:43 PM |
Antal James | Director | May 19, 2011 | Option Exercise | $1.47 | 25,000 | 36,750 | 36,154 | May 23, 2011, 04:41 PM |
Antal James | Director | May 19, 2011 | Sale | $13.64 | 25,000 | 341,000 | 11,154 | May 23, 2011, 04:41 PM |
ROSE ERIC A MD | Chief Executive Officer | May 19, 2011 | Sale | $13.65 | 41,500 | 566,475 | 562,180 | May 20, 2011, 04:25 PM |
CONSTANCE THOMAS E | Director | May 19, 2011 | Sale | $14.03 | 26,267 | 368,438 | 195,000 | May 20, 2011, 04:22 PM |
MacAndrews & Forbes Holdings Inc. | Director | Jan 07, 2011 | Option Exercise | $13.42 | 95,066 | 1,276,071 | 9,253,869 | Jan 11, 2011, 04:35 PM |
MacAndrews & Forbes Holdings Inc. | Director | Jan 07, 2011 | Option Exercise | $1.83 | 697,765 | 1,276,073 | 9,348,935 | Jan 11, 2011, 04:35 PM |
MJALLI ADNAN M M | Director | Sep 30, 2009 | Option Exercise | $7.80 | 444,666 | 3,468,395 | 3,872,952 | Oct 22, 2010, 04:02 PM |
MJALLI ADNAN M M | Director | Sep 30, 2009 | Sale | $6.24 | 3,851,969 | 24,036,286 | 20,983 | Oct 22, 2010, 04:02 PM |
MJALLI ADNAN M M | Director | Sep 30, 2009 | Option Exercise | $1.88 | 1,845,396 | 3,466,392 | 4,317,618 | Oct 22, 2010, 04:02 PM |
TRANSTECH PHARMA INC | 10% Owner | Sep 30, 2009 | Option Exercise | $7.80 | 444,666 | 3,468,395 | 3,872,952 | Oct 22, 2010, 04:01 PM |
TRANSTECH PHARMA INC | 10% Owner | Sep 30, 2009 | Sale | $6.24 | 3,851,969 | 24,036,286 | 20,983 | Oct 22, 2010, 04:01 PM |
TRANSTECH PHARMA INC | 10% Owner | Sep 30, 2009 | Option Exercise | $1.88 | 1,845,396 | 3,466,392 | 4,317,618 | Oct 22, 2010, 04:01 PM |
SAVAS PAUL G | Director | Oct 14, 2010 | Option Exercise | $1.83 | 8,531 | 15,601 | 121,840 | Oct 18, 2010, 07:17 PM |
MacAndrews & Forbes Holdings Inc. | Director | Oct 14, 2010 | Option Exercise | $8.69 | 160,496 | 1,394,148 | 8,651,170 | Oct 18, 2010, 07:13 PM |
MacAndrews & Forbes Holdings Inc. | Director | Oct 14, 2010 | Option Exercise | $1.83 | 762,331 | 1,394,151 | 8,811,666 | Oct 18, 2010, 07:13 PM |
SAVAS PAUL G | Director | Aug 13, 2010 | Option Exercise | $1.83 | 948 | 1,734 | 121,840 | Oct 18, 2010, 07:10 PM |
MacAndrews & Forbes Holdings Inc. | Director | Aug 13, 2010 | Option Exercise | $8.22 | 82,925 | 681,851 | 8,049,335 | Oct 18, 2010, 07:08 PM |
MacAndrews & Forbes Holdings Inc. | Director | Aug 13, 2010 | Option Exercise | $1.83 | 372,842 | 681,853 | 8,132,260 | Oct 18, 2010, 07:08 PM |
MacAndrews & Forbes Holdings Inc. | Director | Sep 30, 2009 | Option Exercise | $7.80 | 444,666 | 3,468,395 | 3,872,952 | Oct 18, 2010, 07:06 PM |
MacAndrews & Forbes Holdings Inc. | Director | Sep 30, 2009 | Buy | $6.24 | 3,851,969 | 24,036,286 | 3,851,969 | Oct 18, 2010, 07:06 PM |
MacAndrews & Forbes Holdings Inc. | Director | Sep 30, 2009 | Option Exercise | $1.88 | 1,845,396 | 3,466,392 | 4,317,618 | Oct 18, 2010, 07:06 PM |
MacAndrews & Forbes Holdings Inc. | Director | Aug 13, 2010 | Option Exercise | $8.22 | 82,924 | 681,843 | 8,035,356 | Aug 17, 2010, 04:39 PM |
MacAndrews & Forbes Holdings Inc. | Director | Aug 13, 2010 | Option Exercise | $1.90 | 358,862 | 681,838 | 8,118,280 | Aug 17, 2010, 04:39 PM |
SAVAS PAUL G | Director | Aug 13, 2010 | Option Exercise | $1.90 | 912 | 1,733 | 121,484 | Aug 17, 2010, 04:37 PM |
Owner | Relationship | Date | Value($) |
Miller Larry R. | General Counsel | 03/25/2024 | 158,984 |
Nabel Gary J. | Director | 06/13/2023 | 26,623 |
DURNAN JAYMIE A | Director | 06/13/2023 | 26,623 |
Nemirovsky Julian | Director | 06/13/2023 | 26,623 |
Phillips Holly L. | Director | 06/13/2023 | 26,623 |
Marshall Joseph W III | Director | 06/13/2023 | 26,623 |
Plansky Michael C. | Director | 06/14/2022 | 70,271 |
Phillips Holly L. | Director | 06/14/2022 | 70,271 |
Nemirovsky Julian | Director | 06/14/2022 | 70,271 |
Nabel Gary J. | Director | 06/14/2022 | 70,271 |
Marshall Joseph W III | Director | 06/14/2022 | 70,271 |
Kane Julie | Director | 06/14/2022 | 70,271 |
DURNAN JAYMIE A | Director | 06/14/2022 | 70,271 |
Antal James | Director | 06/14/2022 | 70,271 |
Antal James | Director | 12/09/2021 | 234,600 |
Luckshire Daniel J | Executive VP & CFO | 07/31/2021 | 88,556 |
Abrams Robin Elizabeth | General Counsel and CAO | 07/31/2021 | 71,987 |
Antal James | Director | 08/27/2020 | 213,000 |
Luckshire Daniel J | Executive VP & CFO | 07/31/2020 | 83,492 |
Abrams Robin Elizabeth | General Counsel and CAO | 07/31/2020 | 90,766 |
SAVAS PAUL G | Director | 12/09/2019 | 87,400 |
Kane Julie | Director | 12/09/2019 | 10,975 |
Gomez Phillip Louis III | Chief Executive Officer | 12/09/2019 | 44,200 |
Luckshire Daniel J | Executive VP & CFO | 12/09/2019 | 21,950 |
Gomez Phillip Louis III | Chief Executive Officer | 11/22/2019 | 708,618 |
ROSE ERIC A MD | Director | 11/22/2019 | 268,145 |
SAVAS PAUL G | Director | 08/23/2019 | 49,500 |
SAVAS PAUL G | Director | 08/09/2019 | 50,800 |
Luckshire Daniel J | Executive VP & CFO | 07/31/2019 | 71,613 |
Abrams Robin Elizabeth | General Counsel and CAO | 07/31/2019 | 71,613 |
BAYER MICHAEL J | Director | 06/04/2019 | 71,750 |
BAYER MICHAEL J | Director | 10/16/2014 | 20,800 |
BAYER MICHAEL J | Director | 09/17/2013 | 29,740 |
Antal James | Director | 06/05/2019 | 171,000 |
Hruby Dennis E | VP & Chief Scientific Officer | 06/05/2019 | 96,560 |
Hruby Dennis E | VP & Chief Scientific Officer | 06/07/2019 | 89,280 |
Hruby Dennis E | VP & Chief Scientific Officer | 06/06/2019 | 94,690 |
Marshall Joseph W III | Director | 01/09/2019 | 118,497 |
Marshall Joseph W III | Director | 01/09/2019 | 118,500 |
Luckshire Daniel J | Executive VP & CFO | 12/12/2018 | 182,557 |
Luckshire Daniel J | Executive VP & CFO | 12/12/2018 | 208,146 |
ROSE ERIC A MD | Director | 11/22/2018 | 587,723 |
Gomez Phillip Louis III | Chief Executive Officer | 11/22/2018 | 1,595,864 |
SAVAS PAUL G | Director | 11/16/2018 | 27,900 |
Hruby Dennis E | VP & Chief Scientific Officer | 11/13/2018 | 164,514 |
Hruby Dennis E | VP & Chief Scientific Officer | 11/12/2018 | 93,749 |
Gomez Phillip Louis III | Chief Executive Officer | 11/12/2018 | 78,000 |
SAVAS PAUL G | Director | 11/12/2018 | 50,100 |
BAYER MICHAEL J | Director | 10/16/2018 | 78,502 |
BAYER MICHAEL J | Director | 10/16/2018 | 78,500 |
Hruby Dennis E | VP & Chief Scientific Officer | 09/11/2018 | 385,559 |
Hruby Dennis E | VP & Chief Scientific Officer | 09/11/2018 | 299,154 |
ROSE ERIC A MD | Executive Chairman | 08/20/2018 | 1,869,530 |
ROSE ERIC A MD | Executive Chairman | 08/20/2018 | 996,000 |
Abrams Robin Elizabeth | General Counsel and CAO | 08/20/2018 | 55,748 |
Antal James | Director | 04/18/2018 | 35,299 |
Antal James | Director | 04/18/2018 | 35,300 |
CONSTANCE THOMAS E | Director | 04/17/2018 | 35,303 |
CONSTANCE THOMAS E | Director | 04/17/2018 | 35,300 |
SAVAS PAUL G | Director | 04/16/2018 | 35,300 |
SAVAS PAUL G | Director | 04/16/2018 | 35,300 |
ROSE ERIC A MD | Executive Chairman | 11/13/2017 | 221,024 |
ROSE ERIC A MD | Executive Chairman | 11/13/2017 | 345,181 |
Hruby Dennis E | VP & Chief Scientific Officer | 11/10/2017 | 135,419 |
Hruby Dennis E | VP & Chief Scientific Officer | 11/10/2017 | 251,223 |
ROSE ERIC A MD | Executive Chairman | 01/03/2017 | 86,441 |
Hruby Dennis E | VP & Chief Scientific Officer | 01/03/2017 | 30,510 |
Luckshire Daniel J | Executive VP & CFO | 01/03/2017 | 41,105 |
Luckshire Daniel J | Executive VP & CFO | 12/08/2016 | 77,032 |
Hruby Dennis E | VP & Chief Scientific Officer | 12/08/2016 | 63,539 |
ROSE ERIC A MD | Executive Chairman | 12/08/2016 | 214,308 |
STERN ANDREW L | Director | 11/16/2016 | 766,838 |
SLOVIN BRUCE | Director | 11/16/2016 | 4,401,068,750 |
SAVAS PAUL G | Director | 11/16/2016 | 6,666,166,676 |
Marshall Joseph W III | Director | 11/16/2016 | 253,500,000 |
Luckshire Daniel J | Executive VP & CFO | 11/16/2016 | 150,000,000 |
KINDLER JEFFREY B | Director | 11/16/2016 | 748,546,382 |
MacAndrews & Forbes Inc. | Director | 11/16/2016 | 1,406,875 |
MacAndrews & Forbes Inc. | Director | 11/16/2016 | 15,090,965 |
CONSTANCE THOMAS E | Director | 11/16/2016 | 1,683,375,000 |
BAYER MICHAEL J | Director | 11/16/2016 | 570,375,000 |
Antal James | Director | 11/16/2016 | 1,380,151,500 |
ROSE ERIC A MD | Chief Executive Officer | 09/24/2015 | 24,200 |
ROSE ERIC A MD | Chief Executive Officer | 09/01/2015 | 26,400 |
ROSE ERIC A MD | Chief Executive Officer | 06/22/2015 | 35,786 |
Luckshire Daniel J | Executive VP & CFO | 06/16/2015 | 11,550 |
Hruby Dennis E | VP & Chief Scientific Officer | 06/03/2015 | 5,340 |
Hruby Dennis E | VP & Chief Scientific Officer | 06/05/2015 | 51,375 |
Hruby Dennis E | VP & Chief Scientific Officer | 06/04/2015 | 8,050 |
ROSE ERIC A MD | Chief Executive Officer | 06/03/2015 | 21,125 |
ROSE ERIC A MD | Chief Executive Officer | 06/02/2015 | 180 |
ROSE ERIC A MD | Chief Executive Officer | 06/04/2015 | 20,336 |
Antal James | Director | 05/28/2015 | 12,200 |
MacAndrews & Forbes Holdings Inc. | Director | 11/07/2014 | 196,913 |
MacAndrews & Forbes Holdings Inc. | Director | 11/06/2014 | 102,207 |
SLOVIN BRUCE | Director | 09/26/2014 | 33,750 |
MacAndrews & Forbes Holdings Inc. | Director | 09/24/2014 | 71,914 |
MacAndrews & Forbes Holdings Inc. | Director | 09/23/2014 | 200,829 |
WEINER MICHAEL MD | Director | 03/13/2014 | 47,850 |
Luckshire Daniel J | Executive VP & CFO | 02/28/2014 | 13,736 |
Hruby Dennis E | VP & Chief Scientific Officer | 02/28/2014 | 28,919 |
ROSE ERIC A MD | Chief Executive Officer | 02/28/2014 | 88,240 |
Luckshire Daniel J | Executive VP & CFO | 01/03/2014 | 47,024 |
Hruby Dennis E | VP & Chief Scientific Officer | 01/03/2014 | 34,880 |
ROSE ERIC A MD | Chief Executive Officer | 01/03/2014 | 97,261 |
Haynes William J II | Executive VP & General Counsel | 01/03/2014 | 37,061 |
Hruby Dennis E | VP & Chief Scientific Officer | 12/17/2013 | 209,997 |
Hruby Dennis E | VP & Chief Scientific Officer | 12/17/2013 | 210,000 |
BAYER MICHAEL J | Director | 09/17/2013 | 33,473 |
BAYER MICHAEL J | Director | 09/16/2013 | 20,263 |
BAYER MICHAEL J | Director | 09/13/2013 | 11,924 |
BAYER MICHAEL J | Director | 09/12/2013 | 41,258 |
SLOVIN BRUCE | Director | 05/30/2013 | 57,510 |
Marshall Joseph W III | Director | 05/24/2013 | 25,130 |
ROSE ERIC A MD | Chief Executive Officer | 02/28/2013 | 116,904 |
Luckshire Daniel J | Executive VP & CFO | 02/28/2013 | 20,672 |
Hruby Dennis E | VP & Chief Scientific Officer | 02/28/2013 | 39,603 |
Bevins William C | Director | 12/30/2011 | 122,055 |
ROSE ERIC A MD | Chief Executive Officer | 11/30/2011 | 259,699 |
Marshall Joseph W III | Director | 09/29/2011 | 15,100 |
SAVAS PAUL G | Director | 09/27/2011 | 42,300 |
SLOVIN BRUCE | Director | 09/27/2011 | 140,000 |
STERN ANDREW L | Director | 08/23/2011 | 7,490 |
Marshall Joseph W III | Director | 08/09/2011 | 16,350 |
SAVAS PAUL G | Director | 08/04/2011 | 62,900 |
TOWNSEND FRANCES F | Director | 08/04/2011 | 12,166 |
SLOVIN BRUCE | Director | 06/15/2011 | 165,500 |
WEINER MICHAEL MD | Director | 05/27/2011 | 141,500 |
CONSTANCE THOMAS E | Director | 05/27/2011 | 424,500 |
ROSE ERIC A MD | Chief Executive Officer | 05/25/2011 | 1,093,903 |
WEINER MICHAEL MD | Director | 05/19/2011 | 37,300 |
WEINER MICHAEL MD | Director | 05/19/2011 | 126,090 |
Hruby Dennis E | Chief Scientific Officer | 05/19/2011 | 750,000 |
Hruby Dennis E | Chief Scientific Officer | 05/20/2011 | 2,539,880 |
Hruby Dennis E | Chief Scientific Officer | 05/19/2011 | 563,332 |
Hruby Dennis E | Chief Scientific Officer | 05/23/2011 | 925,463 |
Antal James | Director | 05/19/2011 | 36,750 |
Antal James | Director | 05/19/2011 | 341,000 |
ROSE ERIC A MD | Chief Executive Officer | 05/19/2011 | 566,475 |
CONSTANCE THOMAS E | Director | 05/19/2011 | 368,438 |
MacAndrews & Forbes Holdings Inc. | Director | 01/07/2011 | 1,276,071 |
MacAndrews & Forbes Holdings Inc. | Director | 01/07/2011 | 1,276,073 |
MJALLI ADNAN M M | Director | 09/30/2009 | 3,468,395 |
MJALLI ADNAN M M | Director | 09/30/2009 | 24,036,286 |
MJALLI ADNAN M M | Director | 09/30/2009 | 3,466,392 |
TRANSTECH PHARMA INC | 10% Owner | 09/30/2009 | 3,468,395 |
TRANSTECH PHARMA INC | 10% Owner | 09/30/2009 | 24,036,286 |
TRANSTECH PHARMA INC | 10% Owner | 09/30/2009 | 3,466,392 |
SAVAS PAUL G | Director | 10/14/2010 | 15,601 |
MacAndrews & Forbes Holdings Inc. | Director | 10/14/2010 | 1,394,148 |
MacAndrews & Forbes Holdings Inc. | Director | 10/14/2010 | 1,394,151 |
SAVAS PAUL G | Director | 08/13/2010 | 1,734 |
MacAndrews & Forbes Holdings Inc. | Director | 08/13/2010 | 681,851 |
MacAndrews & Forbes Holdings Inc. | Director | 08/13/2010 | 681,853 |
MacAndrews & Forbes Holdings Inc. | Director | 09/30/2009 | 3,468,395 |
MacAndrews & Forbes Holdings Inc. | Director | 09/30/2009 | 24,036,286 |
MacAndrews & Forbes Holdings Inc. | Director | 09/30/2009 | 3,466,392 |
MacAndrews & Forbes Holdings Inc. | Director | 08/13/2010 | 681,843 |
MacAndrews & Forbes Holdings Inc. | Director | 08/13/2010 | 681,838 |
SAVAS PAUL G | Director | 08/13/2010 | 1,733 |
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
BLACKROCK INC. | 3,513,890 | 0.0005% | 4.45% | Other |
ROYCE & ASSOCIATES LP | 1,756,311 | 0.09% | 32.37% | Value |
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 1,024,960 | 0.02% | 138.86% | Value |
GEODE CAPITAL MANAGEMENT, LLC | 1,021,653 | 0.0006% | 5.49% | Other |
D. E. SHAW & CO., INC. | 711,729 | 0.00348% | -10.55% | Other |
BALYASNY ASSET MANAGEMENT L.P. | 37,235 | 0.00039% | New | Event Driven |
GOTHAM ASSET MANAGEMENT, LLC | 17,340 | 0.0018% | -29.24% | Other |
RENAISSANCE TECHNOLOGIES LLC | 19,400 | 0.00017% | Exited | Other |
Period of Report: 12/31/2023
10-K/10-Q Filings: View